Efficacy and Safety of Octanorm (Cutaquig®) in Adults With Primary Immunodeficiencies With Predominant Antibody Deficiency: A Prospective, Open-Label Study

Immunotherapy - United Kingdom
doi 10.2217/imt-2020-0012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

An Open Label Study to Evaluate Safety and Efficacy of Unex® Capsules in Patients With Urinary Disorders

Journal of Ayurveda Medical Sciences
2018English

Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)

Journal of the Peripheral Nervous System
MedicineNeuroscienceNeurology
2013English

Clinical Efficacy and Safety of “Vasavaleha” in the Management of Stable Chronic Bronchitis: A Prospective Open Label Multicenter Study

Journal of Research in Ayurvedic Sciences
2017English

A Baseline-Controlled, Open-Label, Flexible Dose-Escalation Study to Assess the Safety and Efficacy of Sildenafil Citrate (Viagra®) in Patients With Erectile Dysfunction

International Journal of Impotence Research
Urology
2003English

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology
Oncology
2011English

Pharmacodynamic and Pharmacokinetic Effects and Safety of Verinurad in Combination With Allopurinol in Adults With Gout: A Phase IIa, Open-Label Study

RMD Open
RheumatologyAllergyImmunology
2018English

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical Therapeutics
Pharmacology
2016English

Clinical Comparison Between Patients With Selective Immunoglobulin a Deficiency and Other Primary Immunodeficiencies

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2015English

Efficacy and Safety of Growth Hormone Replacement Therapy in Japanese Adults With Growth Hormone Deficiency: A Post-Marketing Observational Study

Endocrine Journal
EndocrinologyMetabolismDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy